Cargando…
MYO5A::FGFR1 represents a novel fusion event in pediatric low-grade glioma
Autores principales: | Galvin, Robert T, Zheng, Cynthia, Fitzpatrick, Garrett, Forster, Colleen L, Sandoval-Garcia, Carolina, Guillaume, Daniel, Elbermawy, Ahmed, Nelson, Andrew C, Özütemiz, Can, Chen, Liam, Moertel, Christopher L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10072188/ https://www.ncbi.nlm.nih.gov/pubmed/37025756 http://dx.doi.org/10.1093/noajnl/vdad017 |
Ejemplares similares
-
Spontaneous regression of a congenital high-grade glioma—a case report
por: Riedmeier, Maria, et al.
Publicado: (2021) -
Infantile ZFTA Fusion–Positive Tumor of the Posterior Fossa: Molecular Tumor Board
por: Paulson, Vera A., et al.
Publicado: (2023) -
Durable Near-Complete Response to Olaparib Plus Temozolomide and Radiation in a Patient With ATM-Mutated Glioblastoma and MSH6-Deficient Lynch Syndrome
por: File, Danielle M., et al.
Publicado: (2020) -
Using Advanced Molecular Profiling to Identify the Origin of and Tailor Treatment for an Intracranial Mass of Unknown Primary
por: Martinez, Francisco, et al.
Publicado: (2021) -
Olaparib in the Setting of Radiotherapy-Associated Sarcoma: What Can Precision Medicine Offer For Rare Cancers?
por: Hamdan, Diaddin, et al.
Publicado: (2023)